Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary
3.1. Market Snippet by Drug Class
3.2. Market Snippet by Distribution Channel
3.3. Market Snippet by Region

4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers:
4.1.2. High cost of parenteral nutrition increases demand for SBS drugs
4.2. Restraints:
4.2.1. High cost of treatment
4.3. Opportunity
4.4. Impact Analysis

5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis

6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Drug Class
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
7.1.2. Market Attractiveness Index, By Drug Class
7.2. GLP-2*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Growth Hormone
7.4. Glutamine
7.5. Others

8. By Distribution Channel
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
8.1.2. Market Attractiveness Index, By Distribution Channel
8.2. Hospital Pharmacies*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Retail Pharmacies
8.4. Others

9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape
10.1. Competitive Scenario
10.2. Key Developments and Strategies
10.3. Company Share Analysis
10.4. Product Benchmarking
10.5. Key Companies to Watch
10.6. Company with disruptive technology

11. Company Profiles
11.1. Takeda Pharmaceutical Company Limited*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. OxThera Inc
11.3. VectivBio AG
11.4. Nutrinia
11.5. Merck KGaA
11.6. Pfizer Inc
11.7. Ardelyx
11.8. Zealand Pharma
11.9. Nestl? S.A(*LIST NOT EXHAUSTIVE)

12. DataM Intelligence
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us